New York- Presbyterian Hospital
Low cost pain drug can kill resistant tuberculosis
An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant ...
Diseases, Conditions, Syndromes
Sep 10, 2012 |
5 / 5 (5) |
4
|
Low cost pain drug can kill resistant tuberculosis
An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant ...
Diseases, Conditions, Syndromes
Sep 10, 2012 |
5 / 5 (5) |
4
|
Researchers clock the speed of brain signals
Two studies featuring research from Weill Cornell Medical College have uncovered surprising details about the complex process that leads to the flow of neurotransmitters between brain neurons -- a dance of ...
Neuroscience
Jun 22, 2011 |
4.4 / 5 (14) |
4
|
Double drug combo could shut down abnormal blood vessel growth that feeds disease
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal—such as cancer, diabetic ...
Medical research
Sep 10, 2012 |
5 / 5 (2) |
0
|
Learning to overcome fear is difficult for teens, brain study finds
A new study by Weill Cornell Medical College researchers shows that adolescents' reactions to threat remain high even when the danger is no longer present. According to researchers, once a teenager's brain is triggered by ...
Psychology & Psychiatry
Sep 27, 2012 |
4.2 / 5 (5) |
8
|
New definition of autism in DSM-5 will not exclude most children with autism, new study says
Parents should not worry that proposed changes to the medical criteria redefining a diagnosis of autism will leave their children excluded and deemed ineligible for psychiatric and medical care, says a team of researchers ...
Autism spectrum disorders
Oct 02, 2012 |
4.8 / 5 (4) |
1
|
Two genetic deletions in human genome linked to aggressive prostate cancer development
An international research team led by Weill Cornell Medical College investigators have discovered two inherited-genetic deletions in the human genome linked to development of aggressive prostate cancer. The findings, published ...
Cancer
Apr 09, 2012 |
5 / 5 (1) |
0
|
Distinct molecular subtype of prostate cancer identified
A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers at Weill Cornell Medical ...
Genetics
May 20, 2012 |
5 / 5 (1) |
0
|
Mass spectrometry helps researchers 'watch' how antibiotics attack tuberculosis bacteria inside cells
Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside ...
Medical research
Nov 01, 2012 |
not rated yet |
0
|
Cancerous tumors deliver pro-metastatic information in secreted vesicles
Cancer researchers have known for well over a century that different tumor types spread only to specific, preferred organs. But no one has been able to determine the mechanisms of organ specific metastasis, the so-called ...
Cancer
May 29, 2012 |
4.8 / 5 (6) |
0
|
New gene therapy approach developed for red blood cell disorders
A team of researchers led by scientists at Weill Cornell Medical College has designed what appears to be a powerful gene therapy strategy that can treat both beta-thalassemia disease and sickle cell anemia. They have also ...
Genetics
Mar 27, 2012 |
5 / 5 (5) |
0
|
Scientists unravel role of fusion gene in prostate cancer
Up to half of all prostate cancer cells have a chromosomal rearrangement that results in a new "fusion" gene and formation of its unique protein -- but no one has known how that alteration promotes cancer growth. Now, Weill ...
Cancer
May 22, 2012 |
5 / 5 (3) |
0
|
Researchers reveal crucial immune fighter role of the STING protein
Researchers at Weill Cornell Medical College have unlocked the structure of a key protein that, when sensing certain viruses and bacteria, triggers the body's immediate immune response.
Medical research
Jun 18, 2012 |
5 / 5 (4) |
0
|
Researchers develop novel anti-body vaccine that blocks addictive nicotine chemicals from reaching the brain
Researchers at Weill Cornell Medical College have developed and successfully tested in mice an innovative vaccine to treat nicotine addiction.
Medical research
Jun 27, 2012 |
5 / 5 (7) |
7
|
Study identifies genetic basis of human metabolic individuality
In what is so far the largest investigation of its kind, researchers uncovered a wide range of new insights about common diseases and how they are affected by differences between two persons' genes. The results from this ...
Genetics
Oct 26, 2011 |
3.3 / 5 (3) |
0
|
